Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Riverain Technologies, a clinical artificial intelligence (AI) company with international clients, has expanded this year, recently hiring seven employees. Stephen Keirn and Jason Monnin join the research and development department; Ty Tolley joins installation and services; MaryAnn Besser, Phil Ives, and Emily Stamas join the sales and marketing department; and Marti Lay joins the administrative department.
Keirn joins Riverain Technologies as a senior software engineer. He is responsible for designing, developing, and implementing architectures suitable for computationally intensive applications, employing sophisticated image and AI technologies with demanding run-time requirements.
Monnin has extensive experience developing production-ready algorithms using signal processing, image processing, and machine learning. He is a senior research scientist, who is responsible for research and implementation of advanced image processing using machine learning frameworks.
Tolley has several years of experience with troubleshooting complex issues on production PACS systems with many technologies and tools. Tolley joins as a senior installation and service engineer responsible for installing and configuring Riverain solutions.
Besser brings a successful record in solutions marketing, content development, demand generation, and sales support. As director of marketing, she is responsible for overall marketing operations, driving product sales and visibility and executing strategic marketing programs to achieve key business objectives.
Ives, a seasoned sales veteran joins Riverain as director of sales for the Midwest. He is responsible for achieving the company’s medical device sales in the region.
Stamas has extensive experience in marketing, branding, project development and management, and art direction. As the senior sales and marketing coordinator, she is responsible for planning, designing, and managing marketing campaigns.
Lay has almost 20 years as an office manager and administrator. She will be responsible for a variety of administrative duties to support general office operations.
Steve Worrell, CEO, states, “We’re excited about our expanding team as we scale the organization based on accelerating adoption of our products. There is a tremendous growth opportunity in our industry as AI technology plays an increasing role in healthcare. Our new team members will be instrumental in taking Riverain to the next level.”
This staff growth will advance and support Riverain in the use of AI imaging software used by leading hospitals and radiology reading groups around the world. The ClearRead™ software tools are FDA-cleared, deployable in the clinic or in the cloud, and powered by the most advanced AI and machine learning methods available to the medical imaging market.
Riverain Technologies is still expanding. Current open positions include chief revenue officer, chief product officer, sales position for West Coast as well as research and development positions.
Riverain Technologies is a leader in the commercialization of clinical AI, offering five clinically proven, FDA cleared, thoracic products used to efficiently detect disease at its earliest stages. Riverain developed its ClearRead™ suite of products to improve patient outcomes by aiding clinicians. Riverain was founded in 2004 and is based in Miamisburg, Ohio.